EUVIMEDEUVIMED entdecken
Fallbericht

Botulinum toxin for refractory Raynaud's phenomenon: A “how to” guide for pediatric patients

Kelly K Barry iD, Diana B Reusch, Neda Shahriari, Sarah Lonowski, Fatma Dedeoglu, Ruth Ann Vleugels

Pediatric Dermatology · 2023

DOI: 10.1111/pde.15229 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Dermatology, 2023. Verfasst von Kelly K Barry und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Program, Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Skin Ulcer, Raynaud Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Raynaud's phenomenon describes symptoms caused by digital vascular spasm and is classically induced by cold exposure. Severe cases can result in ulceration, necrosis, and digital autoamputation. When standard and adjunctive medical therapies fail or are contraindicated, botulinum toxin A (BTX‐A) is an effective treatment option that can be added to existing regimens and should be considered before utilizing rescue therapies associated with higher risk and often higher cost. This report describes our technique, highlights considerations relevant to pediatric patients, and provides photos and videos of the procedure performed on a 16‐year‐old girl.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ASkin UlcerRaynaud DiseaseFemaleHumansChildAdolescentTreatment OutcomeNecrosis

Substanzen

Botulinum Toxins, Type A

Autor:innen und Institutionen

  • Dermatology Program, Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Rheumatology Program, Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Kelly K Barry

Zitieren

APA

Barry, K. K., Reusch, D. B., Shahriari, N., Lonowski, S., Dedeoglu, F., & Vleugels, R. A. (2023). Botulinum toxin for refractory Raynaud's phenomenon: A “how to” guide for pediatric patients. Pediatric Dermatology. https://doi.org/10.1111/pde.15229

Vancouver

Barry KK, Reusch DB, Shahriari N, Lonowski S, Dedeoglu F, Vleugels RA. Botulinum toxin for refractory Raynaud's phenomenon: A “how to” guide for pediatric patients. Pediatric Dermatology. 2023. doi:10.1111/pde.15229

BibTeX
@article{Barry2023,
  author = {Barry, Kelly K and Reusch, Diana B and Shahriari, Neda and Lonowski, Sarah and Dedeoglu, Fatma and Vleugels, Ruth Ann},
  title = {Botulinum toxin for refractory Raynaud's phenomenon: A “how to” guide for pediatric patients},
  journal = {Pediatric Dermatology},
  year = {2023},
  doi = {10.1111/pde.15229}
}
Kostenlos starten →